# Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus

> **NCT00496158** · PHASE3 · TERMINATED · sponsor: **Pharmasset**

## Conditions studied

- Chronic Hepatitis
- Hepatitis B

## Interventions

- **DRUG:** Clevudine
- **DRUG:** Adefovir

## Key facts

- **NCT ID:** NCT00496158
- **Lead sponsor:** Pharmasset
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Why stopped:** The study was terminated in the interest of patient safety.
- **Last updated:** 2009-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00496158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00496158, "Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00496158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*